The demonstration that FXR activation protects against the development of inflammation in murine models of colitis, is consistent with the fact that FXR is highly expressed by the intestinal mucosa and regulates the release of FGF15, which in turn modulates bile acid homeostasis and composition of intestinal microbiota. The gene discussed is NR1H4; the disease is colitis.